¼¼°èÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¼ÒÇÁÆ®¿þ¾î¿Í ¼­ºñ½º ½ÃÀå
Remote Patient Monitoring Software and Services
»óǰÄÚµå : 1644057
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 238 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,053,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,161,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¼ÒÇÁÆ®¿þ¾î¿Í ¼­ºñ½º ½ÃÀåÀº 2030³â±îÁö 721¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 124¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¼ÒÇÁÆ®¿þ¾î¿Í ¼­ºñ½º ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 34.1%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 721¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¼­ºñ½º´Â CAGR 31.8%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á±îÁö 511¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¼ÒÇÁÆ®¿þ¾î ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 41.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 33¾ï ´Þ·¯, Áß±¹Àº CAGR 32.5%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¼ÒÇÁÆ®¿þ¾î¿Í ¼­ºñ½º ½ÃÀåÀº 2024³â¿¡ 33¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 109¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 32.5%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 30.8%¿Í 29.8%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 24.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¼ÒÇÁÆ®¿þ¾î¿Í ¼­ºñ½º ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÀÇ·á ºÐ¾ß¿¡¼­ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÌ ±× ¾î´À ¶§º¸´Ù Áß¿äÇÑ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿Í °í·ÉÈ­ Àα¸ Áõ°¡´Â Àü ¼¼°è¿¡¼­ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM) ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ÀÇ·á Àü¹®°¡¿¡°Ô ȯÀÚ µ¥ÀÌÅÍ¿¡ ´ëÇÑ ½Ç½Ã°£ ¾×¼¼½º¸¦ Á¦°øÇÏ¿© Á¶±â °³ÀÔ°ú ´õ ³ªÀº Áúº´ °ü¸®¸¦ °¡´ÉÇÏ°Ô Çϸç, RPMÀº ´ç´¢º´, °íÇ÷¾Ð, ½ÉÇ÷°ü Áúȯ µî »ó½Ã ¸ð´ÏÅ͸µÀ¸·Î ¿¹Èĸ¦ Å©°Ô °³¼±ÇÒ ¼ö ÀÖ´Â Áúº´ °ü¸®¿¡ ƯÈ÷ Áß¿äÇÑ °ÍÀ¸·Î ¹àÇôÁ³½À´Ï´Ù. COVID-19 ÆÒµ¥¹ÍÀº ¿ø°Ý Áø·á¿Í ÀÇ·á ½Ã¼³ÀÇ ºÎ´ãÀ» ´ú¾îÁÙ ¼ö ÀÖ´Â RPMÀÇ ÀáÀç·ÂÀ» ºÎ°¢½Ã۸ç RPMÀÇ Ã¤ÅÃÀ» ´õ¿í °¡¼ÓÈ­Çß½À´Ï´Ù. ±× °á°ú, RPMÀº º¸Á¶ÀûÀÎ ¼­ºñ½º¿¡¼­ Çö´ë ÀÇ·á ½Ã½ºÅÛÀÇ ÇÙ½É ¿ä¼Ò·Î ÀüȯµÇ°í ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀÌ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀ» ¾î¶»°Ô ÀçÁ¤ÀÇÇϰí Àִ°¡?

RPMÀÇ ±Þ¼ÓÇÑ ¹ßÀüÀÇ Á߽ɿ¡´Â IoT Áö¿ø Àåºñ¿Í ¿þ¾î·¯ºí ¼¾¼­¸¦ ÅëÇØ ½É¹Ú¼ö, Ç÷¾Ð, Ç÷´ç µî Áß¿äÇÑ °Ç°­ ÁöÇ¥¸¦ Áö¼ÓÀûÀ¸·Î ¼öÁýÇÒ ¼ö ÀÖ°ÔµÈ ±â¼úÀÌ ÀÖ½À´Ï´Ù. ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×Àº ÀÌ µ¥ÀÌÅ͸¦ ºÐ¼®Çϱâ À§ÇØ ÅëÇյǾî ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô ½Ç¿ëÀûÀÎ ÀλçÀÌÆ®¿Í ¿¹Ãø ºÐ¼®À» Á¦°øÇÕ´Ï´Ù. Ŭ¶ó¿ìµå ÄÄÇ»ÆÃÀº ȯÀÚ µ¥ÀÌÅÍÀÇ ¾ÈÀüÇϰí È®Àå °¡´ÉÇÑ ÀúÀåÀ» º¸ÀåÇϰí, ÇコÄÉ¾î »ýÅÂ°è °£ÀÇ ¿øÈ°ÇÑ °øÀ¯¸¦ ÃËÁøÇÕ´Ï´Ù. ¿ø°ÝÀÇ·áÀÇ ÅëÇÕ ¶ÇÇÑ Áß¿äÇÑ ¹ßÀüÀ¸·Î, RPM µ¥ÀÌÅ͸¦ ±â¹ÝÀ¸·Î ÇÑ ¿ø°Ý Áø·á ¹× Áø´ÜÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¶ÇÇÑ 5G ¿¬°áÀº µ¥ÀÌÅÍ Àü¼ÛÀÇ ¼Óµµ¿Í ½Å·Ú¼ºÀ» Çâ»ó½ÃÄÑ RPMÀÇ ´É·ÂÀ» ´õ¿í Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÇ »õ·Î¿î µ¿Çâ°ú ÀÀ¿ëÀº?

RPMÀÇ ÀÀ¿ëÀº ´Ù¾çÇÑ ÇコÄÉ¾î ºÐ¾ß¿¡¼­ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀçÅÃÄ¡·á´Â °³ÀÎÈ­µÇ°í Æí¸®ÇÑ Ä¡·á¸¦ ¿øÇϴ ȯÀÚµéÀÇ ¼±È£¿¡ ÈûÀÔ¾î Áß¿äÇÑ µ¿ÇâÀÌ µÇ°í ÀÖ½À´Ï´Ù. RPMÀº º´¿ø¿¡¼­ °¡Á¤À¸·ÎÀÇ ÀüȯÀ» Áö¿øÇÏ¿© Ä¡·áÀÇ ¿¬¼Ó¼ºÀ» º¸ÀåÇϰí ÀçÀÔ¿øÀ²À» ³·Ãß´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯ °ü¸® ºÐ¾ß¿¡¼­´Â RPMÀ» ÅëÇØ º¸´Ù Àû±ØÀûÀÌ°í ¸ÂÃãÈ­µÈ Ä¡·á °èȹÀ» ¼ö¸³ÇÒ ¼ö ÀÖÀ¸¸ç, ȯÀÚÀÇ ¼øÀÀµµ¿Í Ä¡·á °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ °¡Ä¡ ±â¹Ý Ä¡·á ¸ðµ¨ÀÇ ºÎ»óÀ¸·Î ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õµéÀº ºñ¿ë È¿À²ÀûÀ̰í È¿À²ÀûÀÎ ¼­ºñ½º¸¦ Á¦°øÇϱâ À§ÇØ RPMÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ »õ·Î¿î µ¿ÇâÀº ÀÓ»ó½ÃÇè¿¡ RPMÀ» Ȱ¿ëÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÓ»ó½ÃÇè Âü°¡ÀÚ¸¦ ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÔÀ¸·Î½á µ¥ÀÌÅÍÀÇ Á¤È®¼º°ú ÄÄÇöóÀ̾𽺸¦ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ½ÃÀåÀÇ ±Þ¼ºÀå ¿øµ¿·ÂÀº?

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¼ÒÇÁÆ®¿þ¾î ¹× ¼­ºñ½º ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯ Áõ°¡·Î ÀÎÇØ »ó½Ã ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇØÁ³°í, RPMÀº ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù. ¿þ¾î·¯ºí ±â¼ú°ú IoT ±â±âÀÇ ¹ßÀüÀ¸·Î ¸ð´ÏÅ͸µÀÌ ´õ¿í Ä£¼÷Çϰí Á¤È®ÇØÁ³½À´Ï´Ù. ¸ÂÃãÇü ÀÇ·á ¹× È¨ÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä Áõ°¡µµ ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¿ø°ÝÀÇ·á¿ÍÀÇ ÅëÇÕÀº RPMÀÇ À¯¿ë¼ºÀ» È®´ëÇÏ¿© ȯÀÚ°¡ ¿ø°ÝÀ¸·Î ÁøÂû ¹× Áø´ÜÀ» ¹ÞÀ» ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. µðÁöÅÐ Çコ ÀÎÇÁ¶ó¿¡ ´ëÇÑ Áö¿øÀûÀÎ ±ÔÁ¦ Á¤Ã¥°ú ÅõÀÚ Áõ°¡·Î ÀÎÇØ äÅÃÀÌ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î RPMÀº ȯÀÚ °á°ú¸¦ °³¼±ÇÏ´Â µ¿½Ã¿¡ ÀÇ·á ºñ¿ëÀ» Àý°¨ÇÏ´Â µ¥ ÁßÁ¡À» µÎ¸é¼­ ÀÇ·á ¼­ºñ½º Á¦°øÀ» Çõ½ÅÇÏ´Â Áß¿äÇÑ Åø·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦°ø(¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¼­ºñ½º, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¼ÒÇÁÆ®¿þ¾î);&ÀÀ¿ë(´ç´¢º´ ¾ÖÇø®ÄÉÀ̼Ç, ½ÉÇ÷°ü Áúȯ ¾ÖÇø®ÄÉÀ̼Ç, ¼ö¸éÀå¾Ö ¾ÖÇø®ÄÉÀ̼Ç, ¾Ï ¾ÖÇø®ÄÉÀ̼Ç, ±âŸ ¾ÖÇø®ÄÉÀ̼Ç);&ÃÖÁ¾»ç¿ëÀÚ( ÇÁ·Î¹ÙÀÌ´õ ÃÖÁ¾»ç¿ëÀÚ, ÁöºÒÀÚ ÃÖÁ¾»ç¿ëÀÚ, ȯÀÚ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÁÖ¸ñ 52»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Remote Patient Monitoring Software and Services Market to Reach US$72.1 Billion by 2030

The global market for Remote Patient Monitoring Software and Services estimated at US$12.4 Billion in the year 2024, is expected to reach US$72.1 Billion by 2030, growing at a CAGR of 34.1% over the analysis period 2024-2030. Remote Patient Monitoring Services, one of the segments analyzed in the report, is expected to record a 31.8% CAGR and reach US$51.1 Billion by the end of the analysis period. Growth in the Remote Patient Monitoring Software segment is estimated at 41.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Billion While China is Forecast to Grow at 32.5% CAGR

The Remote Patient Monitoring Software and Services market in the U.S. is estimated at US$3.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$10.9 Billion by the year 2030 trailing a CAGR of 32.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 30.8% and 29.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 24.0% CAGR.

Global Remote Patient Monitoring Software and Services Market - Key Trends & Drivers Summarized

Why Is Remote Patient Monitoring Gaining Unprecedented Importance in Healthcare?

The rising prevalence of chronic diseases and the increasing aging population are key factors driving the adoption of remote patient monitoring (RPM) solutions globally. These systems provide healthcare professionals with real-time access to patient data, enabling early intervention and better disease management. RPM is proving especially critical in managing conditions such as diabetes, hypertension, and cardiovascular diseases, where constant monitoring can significantly improve outcomes. The COVID-19 pandemic further accelerated its adoption, highlighting its potential to deliver care remotely and reduce the burden on healthcare facilities. As a result, RPM is transitioning from a supplementary service to a core component of modern healthcare systems.

How Are Advancements in Technology Redefining Remote Patient Monitoring?

Technology is at the heart of RPM's rapid evolution. IoT-enabled devices and wearable sensors now allow continuous collection of vital health metrics such as heart rate, blood pressure, and blood glucose levels. Artificial intelligence (AI) and machine learning are being integrated to analyze this data, providing actionable insights and predictive analytics for healthcare providers. Cloud computing ensures secure and scalable storage of patient data, facilitating seamless sharing across healthcare ecosystems. Telehealth integration is another critical advancement, allowing remote consultations and diagnosis based on RPM data. Moreover, 5G connectivity is enhancing the speed and reliability of data transmission, further strengthening RPM’s capabilities.

What Are the Emerging Trends and Applications in Remote Patient Monitoring?

The applications of RPM are expanding across various healthcare sectors. In-home healthcare is a significant trend, driven by patient preferences for personalized and convenient care. Hospital-to-home transitions are also being supported through RPM, ensuring continuity of care and reducing readmission rates. In the realm of chronic disease management, RPM is enabling more proactive and tailored treatment plans, improving patient adherence and outcomes. Additionally, the rise of value-based care models is encouraging healthcare providers to adopt RPM to deliver cost-effective and efficient services. An emerging trend is the use of RPM in clinical trials, where real-time monitoring of participants enhances data accuracy and compliance.

What Drives the Rapid Growth in the Remote Patient Monitoring Market?

The growth in the Remote Patient Monitoring Software and Services market is driven by several factors. The increasing burden of chronic diseases necessitates constant monitoring, making RPM indispensable for healthcare providers. Advances in wearable technology and IoT devices have made monitoring more accessible and accurate. Growing consumer demand for personalized healthcare and home-based care solutions is also fueling market expansion. Additionally, telehealth integration is broadening RPM's utility, allowing patients to receive consultations and diagnoses remotely. Supportive regulatory policies, coupled with increased investment in digital health infrastructure, are further accelerating adoption. Lastly, the focus on reducing healthcare costs while improving patient outcomes positions RPM as a critical tool in transforming healthcare delivery.

SCOPE OF STUDY:

The report analyzes the Remote Patient Monitoring Software and Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Remote Patient Monitoring Services, Remote Patient Monitoring Software); Application (Diabetes Application, Cardiovascular Disease Application, Sleep Disorder Application, Cancer Application, Other Applications); End-User (Providers End-User, Payers End-User, Patients End-User)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 52 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â